慢性疾患管理の世界市場

慢性疾患管理の世界市場は2030年までに117億米ドルに達する見込み

2024年に55億米ドルと推定される慢性疾患管理の世界市場は、分析期間2024-2030年にCAGR 13.3％で成長し、2030年には117億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである心血管疾患管理は、CAGR 15.5%を記録し、分析期間終了時には36億米ドルに達すると予測されます。糖尿病管理分野の成長率は、分析期間のCAGRで14.9％と推定されます。

米国市場は15億米ドルと推定、中国はCAGR 18.1％で成長予測

米国の慢性疾患管理市場は2024年に15億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 18.1%で推移し、2030年には25億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.5％と12.0％と予測されています。欧州では、ドイツがCAGR 10.6%で成長すると予測されています。

世界の慢性疾患管理市場- 主要動向と促進要因のまとめ

慢性疾患管理が世界ヘルスケアの持続可能性の中心になりつつあるのはなぜか？

心血管疾患、糖尿病、がん、呼吸器疾患、神経変性疾患などの慢性疾患は、世界の罹患率、死亡率、医療費の大半を占めています。高齢化が進み、ライフスタイルに関連した危険因子が急増する中、世界の医療システムは、エピソード型の急性期医療から、継続的で予防的な、アウトカム・ベースの医療モデルへと移行しつつあります。慢性疾患管理（CDM）プログラムは、長期的な患者のモニタリングを調整し、病院での再入院を減らし、生涯にわたる健康状態を持つ個人の生活の質を高めるために不可欠な枠組みとして浮上しています。

このようなモデルでは、積極的なリスク層別化、患者教育、ケアチームの連携、リアルタイムデータの利用を重視し、従来の臨床の場以外での疾患の進行を管理します。早期介入、自己管理、ケアの継続性に重点を置くことで、CDMはケアの総コストを削減し、過度に拡張されたヘルスケア・インフラの負担を軽減します。政府や支払者は、支出額あたりのアウトカムの改善を目指す価値ベースのヘルスケア改革の一環として、CDMの導入にインセンティブを与えるようになってきています。

デジタルヘルス技術と遠隔モニタリングツールは、慢性疾患ケア経路をどのように変革するのか？

デジタルヘルス技術の統合は、慢性疾患の管理、モニタリング、測定方法に革命をもたらしています。遠隔患者モニタリング（RPM）デバイス、ウェアラブルセンサー、AI搭載モバイルアプリ、クラウドベースのプラットフォームは、血糖値、血圧、心拍数、肺機能などの重要な健康指標の継続的な収集と送信を可能にします。これらのツールにより、臨床医は患者の経過をリアルタイムで追跡し、異常を早期に発見し、対面診療を必要とせずに治療計画を個別化することができます。

遠隔医療、電子処方箋、自動化されたアラートは、患者と医療者の相互作用の頻度と質を高め、服薬アドヒアランス、ライフスタイル管理、ケアコーディネーションへの対応を支援します。縦断的な健康データに適用される機械学習アルゴリズムも予測分析を向上させ、高リスク患者や介入トリガーの早期特定を可能にしています。その結果、テクノロジーを活用したCDMは、スケーラブルでコスト効率に優れ、アクセスや利便性に対する患者の期待により合致した、分散型のデータ主導型ケア提供モデルをサポートしています。

市場全体で慢性疾患管理ソリューションの採用を推進している利害関係者は？

支払者と保険会社は、予防可能な入院、緊急医療エピソード、冗長な検査を削減する可能性を認識し、CDM採用の最前線にいます。バンドルペイメント、キャピテーションモデル、慢性期治療への報酬を通じてプロバイダーにインセンティブを与えることで、これらの利害関係者はCDMをヘルスケア提供の経済的基盤に組み込もうとしています。雇用主もまた、保険料を抑制し、欠勤を減らし、従業員の生産性を高めるために、職場のウェルネスや疾病管理プログラムを導入しています。

病院、医師ネットワーク、ACO（アカウンタブル・ケア・オーガニゼーション）は、CDMを電子カルテ（EHR）、症例管理ワークフロー、退院計画に組み込む統合ケアモデルに投資しています。製薬会社は、治療のアドヒアランスとアウトカムを改善するための付加価値サービスやデジタル治療薬を通じて、この分野に参入しています。先進国市場でも新興国市場でも、政府は公衆衛生キャンペーン、国家デジタルヘルス・ミッション、そしてCDMを公衆衛生上の必須事項として位置づける的を絞った資金提供イニシアティブを通じて、慢性期医療のインフラを拡大しています。

慢性疾患管理の将来に影響を与えうる規制、償還、公平性の課題とは？

市場の見通しは有望であるが、CDMの広範な導入は構造的・規制的な障壁に直面しています。断片的な償還モデル、限られたデータ相互運用性、一貫性のないデジタルヘルス規制が、シームレスなケア連携の妨げとなっています。多くのヘルスケアシステムにおいて、プロバイダーは、患者カウンセリング、遠隔診察、ケアプランニングなど、CDMの中心となる非急性期で時間集約的なサービスに対する報酬が低いままです。アウトカムメトリクスの標準化と、専門分野を超えた協力のインセンティブ付与は、依然として課題です。

さらに、デジタルアクセスの格差は、特に慢性的なケアを最も必要としていながら、デジタルツールを利用する環境が整っていない低所得層、農村部、高齢者層における健康の不平等を悪化させる恐れがあります。プラットフォームの設計、データプライバシーコンプライアンス、患者エンゲージメント戦略における包括性の確保は極めて重要です。利害関係者はまた、安全性、信頼性、説明責任を維持するために、臨床的監督と技術的自動化のバランスを取らなければならないです。的を絞った政策改革、デジタルインフラ投資、人材育成がなければ、医療の不平等とコストを削減するCDMの可能性は限定的なものになるかもしれないです。

慢性疾患管理は、拡大する医療制度への圧力とデジタル移行の中で、スケーラブルなインパクトを提供できるか？

世界のヘルスケアシステムが、財政的負担の増大、労働力不足、慢性疾患の蔓延に直面する中、CDMは戦略的変曲点に立っています。バリュー・ベース・ケア、デジタル・イノベーション、人口動態の必要性が融合することで、CDMは持続可能なヘルスケア提供の核となる柱に位置づけられます。しかし、この可能性を実現するには、規制、経済、技術の枠組みを整合させ、地域やケアの場を超えて、継続的かつ公平で、個別化されたケアをサポートする必要があります。

持続的な成功には、セクターを超えた強固なパートナーシップ、診療報酬改革、デジタルリテラシーへの投資、AI、アナリティクス、遠隔ツールの拡張可能な統合が必要となります。慢性疾患管理は、長期的なシステム全体の節約、集団の健康状態の改善、質の高いケアへの普遍的なアクセスを実現しながら、高まる患者の需要に応えるために、迅速かつ包括的に進化することができるのだろうか？

セグメント

疾患タイプ（心血管疾患、糖尿病、呼吸器疾患、がん、慢性腎臓病、その他の疾患タイプ）、サービスタイプ（疾患管理プログラム、遠隔患者モニタリング、テレヘルスサービス、その他のサービスタイプ）、展開（オンプレミス、ウェブベース、クラウド）、エンドユーザー（病院、専門クリニック、在宅ケア設定、その他のエンドユーザー）

調査対象企業の例（注目の44社）

• Altruista Health
• Biofourmis
• CareHarmony
• Cedar Gate Technologies
• Cognizant
• Cosan Group
• Epic Systems Corporation
• Health Catalyst
• Infosys Limited
• MINES and Associates
• NXGN Management（NextGen Healthcare）
• Pegasystems Inc.
• Philips Healthcare
• ScienceSoft USA Corporation
• Siemens Healthineers
• TriZetto Corporation
• Veradigm Inc.（formerly Allscripts）
• Vida Health
• WellSky Corporation
• ZeOmega

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Chronic Disease Management Market to Reach US$11.7 Billion by 2030

The global market for Chronic Disease Management estimated at US$5.5 Billion in the year 2024, is expected to reach US$11.7 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Cardiovascular Diseases Management, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Diabetes Management segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 18.1% CAGR

The Chronic Disease Management market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 18.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.5% and 12.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Chronic Disease Management Market - Key Trends & Drivers Summarized

Why Is Chronic Disease Management Becoming Central to Global Healthcare Sustainability?

Chronic diseases-including cardiovascular disorders, diabetes, cancer, respiratory illnesses, and neurodegenerative conditions-account for the majority of global morbidity, mortality, and healthcare expenditure. As aging populations grow and lifestyle-related risk factors proliferate, health systems worldwide are shifting from episodic, acute care to continuous, preventive, and outcomes-based models of care. Chronic Disease Management (CDM) programs are emerging as essential frameworks to coordinate long-term patient monitoring, reduce hospital readmissions, and enhance quality of life for individuals with lifelong health conditions.

These models emphasize proactive risk stratification, patient education, care team collaboration, and use of real-time data to manage disease progression outside of traditional clinical settings. By focusing on early intervention, self-management, and continuity of care, CDM reduces total cost of care and eases the burden on overextended healthcare infrastructure. Governments and payers are increasingly incentivizing CDM adoption as part of value-based healthcare reforms aimed at improving outcomes per dollar spent.

How Are Digital Health Technologies and Remote Monitoring Tools Transforming Chronic Disease Care Pathways?

The integration of digital health technologies is revolutionizing how chronic conditions are managed, monitored, and measured. Remote patient monitoring (RPM) devices, wearable sensors, AI-powered mobile apps, and cloud-based platforms enable continuous collection and transmission of vital health metrics such as blood glucose, blood pressure, heart rate, and pulmonary function. These tools allow clinicians to track patient progress in real-time, detect anomalies early, and personalize treatment plans without requiring in-person visits.

Telemedicine, e-prescriptions, and automated alerts enhance the frequency and quality of patient-provider interactions, helping address medication adherence, lifestyle management, and care coordination. Machine learning algorithms applied to longitudinal health data are also improving predictive analytics, enabling earlier identification of high-risk patients and intervention triggers. As a result, technology-enabled CDM is supporting decentralized, data-driven care delivery models that are scalable, cost-efficient, and better aligned with patient expectations for accessibility and convenience.

Which Stakeholders Are Driving the Adoption of Chronic Disease Management Solutions Across Markets?

Payers and insurers are at the forefront of CDM adoption, recognizing its potential to reduce preventable hospitalizations, emergency care episodes, and redundant testing. By incentivizing providers through bundled payments, capitation models, and chronic care reimbursements, these stakeholders are embedding CDM into the economic foundation of healthcare delivery. Employers are also adopting workplace wellness and disease management programs to control insurance premiums, reduce absenteeism, and boost employee productivity.

Hospitals, physician networks, and accountable care organizations (ACOs) are investing in integrated care models that embed CDM into electronic health records (EHRs), case management workflows, and discharge planning. Pharmaceutical companies are entering the space through value-added services and digital therapeutics designed to improve treatment adherence and outcomes. Governments in both developed and emerging markets are expanding chronic care infrastructure through public health campaigns, national digital health missions, and targeted funding initiatives that position CDM as a public health imperative.

What Regulatory, Reimbursement, and Equity Challenges Could Impact the Future of Chronic Disease Management?

While the market outlook is promising, widespread CDM implementation faces structural and regulatory barriers. Fragmented reimbursement models, limited data interoperability, and inconsistent digital health regulations hinder the seamless coordination of care. In many healthcare systems, providers remain undercompensated for non-acute, time-intensive services central to CDM, including patient counseling, remote consultations, and care planning. Standardizing outcome metrics and incentivizing cross-specialty collaboration remain ongoing challenges.

Additionally, digital access disparities threaten to exacerbate health inequities, especially among low-income, rural, and elderly populations who are most in need of chronic care but least equipped to engage with digital tools. Ensuring inclusivity in platform design, data privacy compliance, and patient engagement strategies is critical. Stakeholders must also balance clinical oversight with technological automation to maintain safety, trust, and accountability. Without targeted policy reform, digital infrastructure investment, and workforce training, the potential of CDM to reduce healthcare inequities and costs may be limited.

Can Chronic Disease Management Deliver Scalable Impact Amid Growing Health System Pressures and Digital Transition?

As global healthcare systems face mounting financial strain, workforce shortages, and chronic disease prevalence, CDM stands at a strategic inflection point. The convergence of value-based care, digital innovation, and demographic necessity positions CDM as a core pillar of sustainable healthcare delivery. However, realizing this potential depends on aligning regulatory, economic, and technological frameworks to support continuous, equitable, and personalized care across geographies and care settings.

Sustained success will require robust cross-sector partnerships, reimbursement reform, investment in digital literacy, and scalable integration of AI, analytics, and remote tools. The question ahead is clear: Can chronic disease management evolve rapidly and inclusively enough to meet rising patient demands-while delivering long-term system-wide savings, population health improvement, and universal access to quality care?

SCOPE OF STUDY:

The report analyzes the Chronic Disease Management market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Type (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease, Other Disease Types); Service Type (Disease Management Programs, Remote Patient Monitoring, Telehealth Services, Other Service Types); Deployment (On-Premise, Web-based, Cloud); End-User (Hospitals, Specialty Clinics, Home Care Settings, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Altruista Health
• Biofourmis
• CareHarmony
• Cedar Gate Technologies
• Cognizant
• Cosan Group
• Epic Systems Corporation
• Health Catalyst
• Infosys Limited
• MINES and Associates
• NXGN Management (NextGen Healthcare)
• Pegasystems Inc.
• Philips Healthcare
• ScienceSoft USA Corporation
• Siemens Healthineers
• TriZetto Corporation
• Veradigm Inc. (formerly Allscripts)
• Vida Health
• WellSky Corporation
• ZeOmega

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Chronic Disease Management - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Shift Toward Value-Based Care Models Elevates Importance of Chronic Disease Management Platforms
  • Multimorbidity in Aging Populations Drives Demand for Integrated, Long-Term Health Interventions
  • Remote Patient Monitoring (RPM) Tools Enable Proactive Management of Diabetes, CVD, and COPD
  • AI and Predictive Analytics Improve Risk Stratification and Personalized Care Pathways
  • Digital Therapeutics and App-Based Coaching Programs Improve Patient Engagement and Adherence
  • Virtual Care Models Expand Access to Rural and Underserved Populations With Chronic Conditions
  • Wearables and Home Diagnostics Devices Streamline Data Collection for Longitudinal Monitoring
  • Pharmaceutical Companies Integrate Companion Apps With Drug Adherence Tools for Better Outcomes
  • Self-Management Education and Behavioral Health Integration Improve Quality of Life Metrics
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Chronic Disease Management Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Chronic Kidney Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Chronic Kidney Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Chronic Kidney Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Disease Management Programs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Disease Management Programs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Disease Management Programs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Remote Patient Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Remote Patient Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Remote Patient Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Telehealth Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Telehealth Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Telehealth Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Web-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Web-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Web-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 56: USA Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Canada 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 92: China Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: China 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: China 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Chronic Disease Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 119: France Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: France 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: France 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Germany 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Germany 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Italy 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Italy 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Italy 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 155: UK Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: UK 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 161: UK Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: UK 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: UK 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Spain 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Spain 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Spain 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Russia 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Russia 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Russia 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Chronic Disease Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Australia 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Australia 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Australia 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 230: India Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: India 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 236: India Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: India 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: India 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: South Korea 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: South Korea 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: South Korea 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Chronic Disease Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Latin America 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Argentina 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Argentina 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Argentina 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Brazil 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Brazil 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Brazil 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Mexico 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Mexico 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Mexico 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Chronic Disease Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Middle East 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Iran 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Iran 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Iran 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Israel 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Israel 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Israel 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: UAE 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: UAE 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: UAE 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Chronic Disease Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Chronic Disease Management by Disease Type - Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Chronic Disease Management by Disease Type - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease and Other Disease Types for the Years 2015, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Chronic Disease Management by Service Type - Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Africa 15-Year Perspective for Chronic Disease Management by Service Type - Percentage Breakdown of Value Sales for Other Service Types, Disease Management Programs, Remote Patient Monitoring and Telehealth Services for the Years 2015, 2025 & 2030
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Chronic Disease Management by Deployment - On-Premise, Web-based and Cloud Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Africa 15-Year Perspective for Chronic Disease Management by Deployment - Percentage Breakdown of Value Sales for On-Premise, Web-based and Cloud for the Years 2015, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Chronic Disease Management by End-user - Hospitals, Specialty Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Africa 15-Year Perspective for Chronic Disease Management by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION